Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Clinical and Translational Oncology
Published in: Clinical and Translational Oncology 2/2003

01-03-2003 | Originales

Bioquimioterapia ambulatoria con cisplatino, dacarbacina, interleucina-2 e interferón-alfa en pacientes con melanoma avanzado. Estudio multicéntrico en 44 pacientes

Authors: Elena Filipovich Vegas, José Ignacio Mayordomo Cámara, José Anadrés Meana García, Manuel Valladares Ayerbes, Jesús Florián Jericó, Juan José Bretón García, Remedios Blanco Guerrero, Dolores Isla Casado, Carmen Santander Lobera, Raquel Andrés Conejero, Bartolomeu Massuti Sureda, Alejandro Tres Sánchez

Published in: Clinical and Translational Oncology | Issue 2/2003

Login to get access
Metadata
Title
Bioquimioterapia ambulatoria con cisplatino, dacarbacina, interleucina-2 e interferón-alfa en pacientes con melanoma avanzado. Estudio multicéntrico en 44 pacientes
Authors
Elena Filipovich Vegas
José Ignacio Mayordomo Cámara
José Anadrés Meana García
Manuel Valladares Ayerbes
Jesús Florián Jericó
Juan José Bretón García
Remedios Blanco Guerrero
Dolores Isla Casado
Carmen Santander Lobera
Raquel Andrés Conejero
Bartolomeu Massuti Sureda
Alejandro Tres Sánchez
Publication date
01-03-2003
Publisher
Springer Milan
Published in
Clinical and Translational Oncology / Issue 2/2003
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI
https://doi.org/10.1007/BF02728200

Other articles of this Issue 2/2003

Clinical and Translational Oncology 2/2003 Go to the issue

Sección Docente

Selective biopsy of the sentinel node: technique and present state in the different tumors

Originales

The addition of oxaliplatin to the mayo clinic schedule significantly increases its toxicity: a retrospective analysis of patients with advanced colorectal cancer

Artículo Especial

X Curso internacional de avances en Oncología: investigación y nuevos fármacos

Originales

Local recurrence after breast conserving therapy for invasive breast cancer: analysis of prognostic factors

Announcement

Información

Sección Docente

Introduction to the teaching course in surgical oncology
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits